Shandong Pharmaceutical Glass Co., Ltd.SSE: 600529

Report for Q1 2026

Apr 25, 2026 · Issued by Shandong Pharmaceutical Glass Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Apr 25, 2026

On 6ix: 6ix.com/news/report-for-q1-2026-123

Report for Q1 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Shandong Pharmaceutical Glass Co., Ltd. on 6ix

Earlier from Shandong Pharmaceutical Glass

Report on Utilization of Proceeds from Previous Capital RaisingApr 11
Announcement on Progress in Redemption upon Maturity of Structural Deposits Purchased with Partial Idle Raised Funds and Continuing Purchase of Structural DepositsApr 3
Announcement on Resolutions of the 2025 Annual General MeetingMar 28
Announcement on Progress in Using Idle Raised Funds to Purchase Wealth Management ProductsMar 20
Announcement on Convening the 2025 Annual Performance BriefingMar 14

Later from Shandong Pharmaceutical Glass

Announcement on Convening the Q1 2026 Performance BriefingApr 29
Announcement on Attending the 2026 Online Collective Reception Day for Investors of Listed Companies in the Shandong JurisdictionMay 8
Announcement on Implementation of Dividend Distribution for 2025May 13
Announcement on Change of Sponsor RepresentativeJun 12
Announcement on Progress in Issuance of Shares to Specific Investors Involving a Change of ControlJun 19

All Shandong Pharmaceutical Glass news releases

Follow Shandong Pharmaceutical Glass into a list and get an email when it puts out news.

Follow Shandong Pharmaceutical Glass